Macromastia
9
2
2
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
22.2%
2 terminated out of 9 trials
71.4%
-15.1% vs benchmark
22%
2 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
NPWT Reduction Mammaplasty
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
Comparison of ESP and SPSIP Blocks in Breast Surgery
Satisfaction, Pain and Function Outcomes of Breast Reduction Patients
Reduction Mammaplasty and Improved Quality of Life
An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy
A Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0
PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction
Study of Prineo (Dermabond Protape) Versus Sutures in Breast Procedures